GMP for Cannabis – what you need to know - Live Online Conference
All relevant GMP/GACP aspects for Medical Cannabis
19/20 May 2026
Course No. 21905
Note: All times mentioned are CEST.
Target Group
This Live Online Conference addresses specific GMP aspects to consider for Growers, Manufacturers, Start-Ups, Suppliers, Importers, Wholesalers, QPs and QA/QC personnel involved in Cannabis production and release. The topics provided are also of interest for GACP/GMP/GDP Inspectors responsible for issuing a "GMP certificate" or manufacturers/import license.
Objectives
Medical cannabis has been meanwhile permitted for prescription in several countries around the world, causing a need for producers supplying pharmacists and physicians with the newly legalized drug. But what qualifies as medical grade cannabis? And which aspects have to be considered for CBD-Products? This conference will give you an overview of all relevant GACP/GMP requirements and regulatory aspects for medical cannabis and CBD-Products.
Background
Medical cannabis products must comply with the relevant requirements laid down under Medicinal and Narcotics Law. The relevant requirements based on the underlying legal framework (including Pharmacopoeias) and the corresponding EU GMP/ GDP and GACP guidelines must be complied with when supplying medical cannabis to the EU market.
The EU GMP inspectorates are responsible for issuing manufacturing and import licenses or “GMP Certificates”. Thus, they will perform inspections at the sites of manufacturers who apply for these certificates and licenses. Meanwhile, European pharmacopoeial (Ph. Eur.) monographs describing the quality requirements for cannabis flower (API or for direct prescription to patients) and for CBD have been established and implemented. However, questions still arise, because:
There is currently no harmonized “EU GMP Cannabis Standard” or “Global GMP Cannabis Standard” available for medical cannabis (API / Herbal Medicinal Product).
The Ph. Eur. Cannabis Flower and CBD monographs are currently not harmonized with the corresponding USP (draft) monographs.
Regarding quality requirements for Cannabis Extracts (Herbal Drug Preparation) only national monographs exist so far.
Thus, national regulations, guidelines and pharmacopoeial monographs will have to be followed and applied in addition to EUGMP.
Programme
Programme – 19 May 2026
Introduction
GMP for Cannabis: setting the scene
Discussion
GMP Certification / Challenges and Experiences from current Inspections
Authorization, registration & import
Which requirements apply?
Current issues
The Intersection between GACP and GMP
When does GACP end and (EU) GMP start?
What will be checked during GACP and EU GMP inspections?
Observations in inspections
Open questions and issues to be solved
Cannabis Cultivation under GACP
Cultivation and the implementation of GACP Standards
Practical insights
Case studies
Final Discussion Day 1
Programme – 20 May 2026
Microbiological Decontamination of Medical Cannabis
Effects of decontamination on cannabis market activity
Cannabis flowers and the microbiological challenges
Landscape of decontamination technologies and limitations
Regulatory Status and Quality Standard of Cannabinoids Manufacture
Pharma, food and cosmetic products and requirements
How to differentiate between CBD/Cannabis Products for medical use and other CBD (Hemp) Products?
Which legal rules apply?
Practical examples
Drying of Medicinal Cannabis – Challenges for Process Validation
Post-harvest processes as a preparation for drying of Medical Cannabis
Drying process - different types of drying
Sampling and testing during drying- what are the challenges?
Validation of the drying process and determination of the end of drying
Curing and why it is needed
Testing after curing and storage of dry cannabis flowers
Discussion
Update from the German Cannabis Agency (Tbc)
Current Status of Medical Cannabis in Germany
Status of Cannabis Monographs (DAB / Ph. Eur.)
Submission requirements for AMRadV applications
Current Challenges
Discussion
Israel Medical Cannabis Regulation
The Israeli Medical Cannabis unit and the licensing process
Major guidelines: IMC-GAP, IMC-GMP, IMC-GDP, IMC-GSP
Technical Requirements We use Webex for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
Fees (per delegate plus VAT) ECA Members € 1,890 APIC Members € 1,990 Non-ECA Members € 2,090 EU GMP Inspectorates € 1,045 The fee is payable in advance after receipt of invoice.
Presentations/Certificate The presentations will be made available to you prior to the Live Online Training as PDF files. After the event, you will automatically receive your certificate of participation.
Conference language The official conference language will be English.
Contacts: Questions regarding content: Dr Andrea Kühn-Hebecker (Operations Director), +49(0)62 21/84 44 35, kuehn@concept-heidelberg.de Questions regarding organisation: Ms Isabell Helm (Organisation Manager), +49(0)62 21/84 44 49, helm@concept-heidelberg.de
Date & Time
Tuesday, 19 May 2026, 12.00 - 18.00 h Wednesday, 20 May 2026, 10.00 - 18.00 h All times mentioned are CEST.
Testimonials
